Martínez Javier, Hernández-Gea Virginia, Rodríguez-de-Santiago Enrique, Téllez Luis, Procopet Bogdan, Giráldez Álvaro, Amitrano Lucio, Villanueva Candid, Thabut Dominique, Ibañez-Samaniego Luis, Silva-Junior Gilberto, Genescà Joan, Bureau Christophe, Trebicka Jonel, Bañares Rafael, Krag Aleksander, Llop Elba, Laleman Wim, Palazon Jose María, Castellote Jose, Rodrigues Susana, Gluud Lise L, Noronha-Ferreira Carlos, Cañete Nuria, Rodríguez Manuel, Ferlitsch Arnulf, Schwarzer Remy, Mundi Jose Luis, Gronbaek Henning, Hernández-Guerra Manuel, Sassatelli Romano, Dell'Era Alessandra, Senzolo Marco, Abraldes Juan G, Romero-Gomez Manuel, Zipprich Alexander, Casas Meritxell, Masnou Helena, Primignani Massimo, Nevens Frederik, Calleja Jose Luis, Jansen Christian, Robic Marie Angèle, Conejo Irene, Catalina Maria Vega, Rudler Marika, Alvarado Edilmar, Perez-Campuzano Valeria, Guardascione Maria Anna, Fischer Petra, Bosch Jaime, García-Pagán Juan Carlos, Albillos Agustín
Servicio de Gastroenterología y Hepatología, Hospital Universitario Ramón y Cajal, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Universidad de Alcalá, Madrid, Spain; Centro de Investigación Biomédica Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Madrid, Spain.
Centro de Investigación Biomédica Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Madrid, Spain; Barcelona Hepatic Hemodynamic Laboratory, Liver Unit, Hospital Clinic, Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.
J Hepatol. 2021 Aug;75(2):342-350. doi: 10.1016/j.jhep.2021.03.026. Epub 2021 Jun 12.
BACKGROUND & AIMS: Antibiotic prophylaxis reduces the risk of infection and mortality in patients with cirrhosis and acute variceal bleeding (AVB). This study examines the incidence of, and risk factors for, bacterial infections during hospitalization in patients with AVB on antibiotic prophylaxis.
A post hoc analysis was performed using the database of an international, multicenter, observational study designed to examine the role of pre-emptive transjugular intrahepatic portosystemic shunts in patients with cirrhosis and AVB. Data were collected on patients with cirrhosis hospitalized for AVB (n = 2,138) from a prospective cohort (October 2013-May 2015) at 34 referral centers, and a retrospective cohort (October 2011-September 2013) at 19 of these centers. The primary outcome was incidence of bacterial infection during hospitalization.
A total of 1,656 patients out of 1,770 (93.6%) received antibiotic prophylaxis; third-generation cephalosporins (76.2%) and quinolones (19.0%) were used most frequently. Of the patients on antibiotic prophylaxis, 320 patients developed bacterial infection during hospitalization. Respiratory infection accounted for 43.6% of infections and for 49.7% of infected patients, and occurred early after admission (median 3 days, IQR 1-6). On multivariate analysis, respiratory infection was independently associated with Child-Pugh C (odds ratio [OR] 3.1; 95% CI 1.4-6.7), grade III-IV encephalopathy (OR 2.8; 95% CI 1.8-4.4), orotracheal intubation for endoscopy (OR 2.6; 95% CI 1.8-3.8), nasogastric tube placement (OR 1.7; 95% CI 1.2-2.4) or esophageal balloon tamponade (OR 2.4; 95% CI 1.2-4.9).
Bacterial infections develop in almost one-fifth of patients with AVB despite antibiotic prophylaxis. Respiratory infection is the most frequent, is an early event after admission, and is associated with advanced liver failure, severe hepatic encephalopathy and use of nasogastric tube, orotracheal intubation for endoscopy or esophageal balloon tamponade.
Bacterial infections develop during hospitalization in close to 20% of patients with acute variceal bleeding despite antibiotic prophylaxis. Respiratory bacterial infections are the most frequent and occur early after admission. Respiratory infection is associated with advanced liver disease, severe hepatic encephalopathy and a need for a nasogastric tube, orotracheal intubation for endoscopy or esophageal balloon tamponade.
抗生素预防可降低肝硬化合并急性静脉曲张出血(AVB)患者的感染风险和死亡率。本研究调查了接受抗生素预防的AVB患者住院期间细菌感染的发生率及危险因素。
使用一项国际多中心观察性研究的数据库进行事后分析,该研究旨在探讨抢先性经颈静脉肝内门体分流术在肝硬化合并AVB患者中的作用。收集了来自34个转诊中心前瞻性队列(2013年10月至2015年5月)及其中19个中心回顾性队列(2011年10月至2013年9月)中因AVB住院的肝硬化患者(n = 2138)的数据。主要结局是住院期间细菌感染的发生率。
1770例患者中有1656例(93.6%)接受了抗生素预防;最常使用的是第三代头孢菌素(76.2%)和喹诺酮类(19.0%)。在接受抗生素预防的患者中,320例在住院期间发生了细菌感染。呼吸道感染占感染的43.6%,占感染患者的49.7%,且在入院后早期发生(中位时间3天,四分位间距1 - 6天)。多因素分析显示,呼吸道感染与Child-Pugh C级(比值比[OR] 3.1;95%置信区间1.4 - 6.7)、III - IV级肝性脑病(OR 2.8;95%置信区间1.8 - 4.4)、内镜检查时气管插管(OR 2.6;95%置信区间1.8 - 3.8)、鼻胃管置入(OR 1.7;95%置信区间1.2 - 2.4)或食管气囊压迫(OR 2.4;95%置信区间1.2 - 4.9)独立相关。
尽管进行了抗生素预防,近五分之一的AVB患者仍发生细菌感染。呼吸道感染最为常见,是入院后的早期事件,且与晚期肝功能衰竭、严重肝性脑病以及鼻胃管使用、内镜检查时气管插管或食管气囊压迫有关。
尽管进行了抗生素预防,但近20%的急性静脉曲张出血患者在住院期间仍发生细菌感染。呼吸道细菌感染最为常见,且在入院后早期发生。呼吸道感染与晚期肝病、严重肝性脑病以及需要鼻胃管、内镜检查时气管插管或食管气囊压迫有关。